Search Results - "Guney Eskiler, G"
-
1
The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma
Published in Human & experimental toxicology (01-02-2019)“…Usnic acid (UA) is a multifunctional bioactive lichen secondary metabolite with potential anti-cancer properties. Although the promising therapeutic effects of…”
Get more information
Journal Article -
2
IL-6 mediated JAK/STAT3 signaling pathway in cancer patients with cachexia
Published in Bratislavské lékarské listy (01-01-2019)“…OBJECTIVESWe investigated the changes in the IL-6 and STAT3 expression levels in cachectic and non-cachectic patients with gastric, lung and breast cancer and…”
Get full text
Journal Article -
3
Association of PALB2 sequence variants with the risk of early-onset breast cancer in patients from Turkey
Published in Molecular biology reports (01-11-2016)“…The PALB2 gene, has been accepted as a moderate-penetrance gene associated with breast cancer susceptibility and this gene product is involved in the DNA…”
Get full text
Journal Article -
4
A novel [Mn2(μ-(C6H5)2CHCOO)2(bipy)4](bipy)(ClO4)2 complex loaded solid lipid nanoparticles: synthesis, characterization and in vitro cytotoxicity on MCF-7 breast cancer cells
Published in Journal of microencapsulation (01-09-2016)“…Manganese (Mn)-based complexes have been drawing attention due to the fact that they are more effective than other metal complexes. However, the use of…”
Get full text
Journal Article -
5
The anti-proliferative and apoptotic effects of curcumin on feline mammary gland tumor cells in vitro
Published in Iranian journal of veterinary research (01-01-2021)“…Feline mammary gland tumors (FMGTs) are the third most diagnosed tumors in cats. Feline mammary gland tumors have aggressive biological behavior and poor…”
Get full text
Journal Article -
6
Talazoparib to treat BRCA-positive breast cancer
Published in Drugs of today (Barcelona, Spain : 1998) (01-07-2019)“…Talazoparib tosylate (BMN-673, Talzenna; Pfizer) is an oral poly [ADP-ribose] polymerase (PARP) inhibitor (PARPi) that has been approved by the U.S. Food and…”
Get full text
Journal Article -
7
P110 The predictive role of SHARP1 and SHARP2 transcription factors in patients with breast cancer upon neoadjuvan chemotherapy
Published in Breast (Edinburgh) (01-04-2023)Get full text
Journal Article -
8
Association BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer
Published in Annals of oncology (01-09-2018)Get full text
Journal Article -
9
Synthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cancer
Published in Annals of oncology (01-09-2018)Get full text
Journal Article -
10
75PSynthetic lethal effects of BMN 673 loaded solid lipid nanoparticles on triple-negative breast cancer
Published in Annals of oncology (01-09-2018)Get full text
Journal Article -
11
67PAssociation BRCA mutation status between BMN 673 (talazoparib), an oral PARP inhibitor, in triple-negative breast cancer
Published in Annals of oncology (01-09-2018)Get full text
Journal Article